Mereo BioPharma (MREO) EBIT (2023 - 2026)
Mereo BioPharma (MREO) posted quarterly EBIT of -$8.8 million for Q1 2026, up 21.75% year-over-year from -$7.2 million in Q1 2025, and down 4.48% quarter-over-quarter from -$8.4 million in Q4 2025.
Mereo BioPharma (MREO) EBIT (2023 - 2026) Analysis & Trends
Mereo BioPharma (MREO) has reported EBIT for 4 consecutive years, with -$8.8 million the latest figure, recorded in Q1 2026.
- In Q1 2026, EBIT rose 21.75% year-over-year to -$8.8 million; the TTM figure through Mar 2026 stood at -$37.7 million (up 22.59% YoY), while the FY2025 annual figure was -$40.1 million, up 15.32% from the prior year.
- EBIT fell to -$8.8 million in Q1 2026 per MREO's latest filing, from -$8.4 million in the prior quarter.
- Across five years, EBIT topped out at -$811000.0 in Q2 2023 and bottomed at -$15.3 million in Q4 2024.
- Historically, EBIT has averaged -$9.6 million across 4 years, with a median of -$9.9 million in 2024.
- Annual changes were most pronounced in 2024 — EBIT tumbled 1480.02% — and 2025, when it surged 45.07%.
- Mereo BioPharma's EBIT stood at -$7.1 million in 2023, then tumbled by 114.3% to -$15.3 million in 2024, then jumped by 45.07% to -$8.4 million in 2025, then retreated by 4.48% to -$8.8 million in 2026.
- Business Quant data shows MREO's EBIT at -$8.8 million in Q1 2026, -$8.4 million in Q4 2025, and -$10.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.41 Bn | 131.56 Bn | 2.84 Bn | 1.25 Bn |
| 2 | Regeneron Pharmaceuticals | 86.14 Bn | 78.15 Bn | 3.93 Bn | 1.29 Bn |
| 3 | Argenx Se | 65.52 Bn | 60.34 Bn | 1.37 Bn | 493.00 Mn |
| 4 | Moderna | 58.21 Bn | 53.07 Bn | 52.00 Mn | -815.00 Mn |
| 5 | BeOne Medicines | 42.15 Bn | 37.05 Bn | 1.53 Bn | 325.05 Mn |
| 6 | Alnylam Pharmaceuticals | 31.62 Bn | 28.31 Bn | 992.69 Mn | 231.44 Mn |
| 7 | BioNTech SE | 27.95 Bn | 9.56 Bn | 668.28 Mn | -375.75 Mn |
| 8 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -1.55 Mn |
| 9 | Royalty Pharma | 27.30 Bn | 26.46 Bn | - | 133.12 Mn |
| 10 | Mereo BioPharma | 47.41 Mn | 47.41 Mn | - | -7.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -7.03 Mn |
| Mar 31, 2026 | -8.77 Mn |
| Dec 31, 2025 | -8.39 Mn |
| Sep 30, 2025 | -10.02 Mn |
| Jun 30, 2025 | -10.50 Mn |
| Mar 31, 2025 | -11.20 Mn |
| Dec 31, 2024 | -15.28 Mn |
| Sep 30, 2024 | -9.37 Mn |
| Jun 30, 2024 | -12.81 Mn |
| Mar 31, 2024 | -9.90 Mn |
| Dec 31, 2023 | -7.13 Mn |
| Sep 30, 2023 | -9.07 Mn |
| Jun 30, 2023 | -811,000.00 |
| Mar 31, 2023 | -11.41 Mn |